The stem cell regulatory environment in South Africa - Cause for concern

South African Medical Journal

Volumn 99, Issue 7, 2009, Pages 505-507

  Pepper, Michael S ^a,b  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATAXIA TELANGIECTASIA; BRAIN TUMOR; CLINICAL PRACTICE; GOVERNMENT REGULATION; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; INTERNATIONAL COOPERATION; LOCKED IN SYNDROME; MALPRACTICE; MEDICAL ETHICS; MEDICOLEGAL ASPECT; NEURAL STEM CELL TRANSPLANTATION; PATIENT SAFETY; PRACTICE GUIDELINE; RISK BENEFIT ANALYSIS; SOUTH AFRICA; SPINAL CORD INJURY; STEM CELL TRANSPLANTATION;

EID: 70049117567     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Macchiarini P, Jungebluth P, Go T, et al. Clinical transplantation of a tissue-engineered airway. Lancet 2008; 372: 2023-2030.
2. Duke University School of Medicine, Department of Pediatrics. http://pediatrics.duke.edu/modules/dept_peds_annc/index.php?id=79 (accessed 13 May 2009).
3. Amariglio N, Hirshberg A, Scheithauer BW, et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med 6(2): e1000029. doi:10.1371/ journal.pmed.1000029.